|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hornsveld M and Dansen TB: The hallmarks
of cancer from a redox perspective. Antioxid Redox Signal.
25:300–325. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lu J and Holmgren A: Thioredoxin system in
cell death progression. Antioxid Redox Signal. 17:1738–1747.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang J, Li X, Han X, Liu R and Fang J:
Targeting the thioredoxin system for cancer therapy. Trends
Pharmacol Sci. 38:794–808. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Haas B, Schütte L, Wos-Maganga M,
Weickhardt S, Timmer M and Eckstein N: Thioredoxin confers
intrinsic resistance to cytostatic drugs in human glioma cells. Int
J Mol Sci. 19(2874)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Selenius M, Hedman M, Brodin D, Gandin V,
Rigobello MP, Flygare J, Marzano C, Bindoli A, Brodin O, Björnstedt
M and Fernandes AP: Effects of redox modulation by inhibition of
thioredoxin reductase on radiosensitivity and gene expression. J
Cell Mol Med. 16:1593–1605. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y,
Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin
expression is associated with resistance to docetaxel in primary
breast cancer. Clin Cancer Res. 11:8425–8430. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fang J, Lu J and Holmgren A: Thioredoxin
reductase is irreversibly modified by curcumin: A novel molecular
mechanism for its anticancer activity. J Biol Chem.
280:25284–25290. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Panda AK, Chakraborty D, Sarkar I, Khan T
and Sa G: New insights into therapeutic activity and anticancer
properties of curcumin. J Exp Pharmacol. 9:31–45. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu J, Pan Y, Chen O, Luan Y, Xue X, Zhao
J, Liu L and Jia HY: Curcumin inhibits MCF-7 cells by modulating
the NF-κB signaling pathway. Oncol Lett. 14:5581–5584.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hewlings SJ and Kalman DS: Curcumin: A
review of its' effects on human health. Foods. 6(92)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zou J, Zhu L, Jiang X, Wang Y, Wang Y,
Wang X and Chen B: Curcumin increases breast cancer cell
sensitivity to cisplatin by decreasing FEN1 expression. Oncotarget.
9:11268–11278. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Javvadi P, Hertan L, Kosoff R, Datta T,
Kolev J, Mick R, Tuttle SW and Koumenis C: Thioredoxin reductase-1
mediates curcumin-induced radiosensitization of squamous carcinoma
cells. Cancer Res. 70:1941–1950. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Duval K, Grover H, Han LH, Mou Y, Pegoraro
AF, Fredberg J and Chen Z: Modeling physiological events in 2D vs.
3D cell culture. Physiology (Bethesda). 32:266–277. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kapałczyńska M, Kolenda T, Przybyła W,
Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski
Ł and Lamperska K: 2D and 3D cell cultures-a comparison of
different types of cancer cell cultures. Arch Med Sci. 4:910–919.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Knight E and Przyborski S: Advances in 3D
cell culture technologies enabling tissue-like structures to be
created in vitro. J Anat. 227:746–756. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vantangoli MM, Madnick SJ, Huse SM, Weston
P and Boekelheide K: MCF-7 human breast cancer cells form
differentiated microtissues in scaffold-free hydrogels. PLoS One.
10(e0135426)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Imamura Y, Mukohara T, Shimono Y,
Funakoshi Y, Chayahara N, Toyoda M, Kiyota N, Takao S, Kono S,
Nakatsura T and Minami H: Comparison of 2D- and 3D-culture models
as drug-testing platforms in breast cancer. Oncol Rep.
33:1837–1843. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shi J, Zhang X, Shi T and Li H: Antitumor
effects of curcumin in human bladder cancer in vitro. Oncol
Lett. 14:1157–1161. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Teiten MH, Gaascht F, Cronauer M, Henry E,
Dicato M and Diederich M: Anti-proliferative potential of curcumin
in androgen-dependent prostate cancer cells occurs through
modulation of the wingless signaling pathway. Int J Oncol.
38:603–611. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang J, Wang C and Bu G: Curcumin inhibits
the growth of liver cancer stem cells through the
phosphatidylinositol 3-kinase/protein kinase B/mammalian target of
rapamycin signaling pathway. Exp Ther Med. 15:3650–3658.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Perrone D, Ardito F, Giannatempo G,
Dioguardi M, Troiano G, Lo Russo L, DE Lillo A, Laino L and Lo
Muzio L: Biological and therapeutic activities, and anticancer
properties of curcumin. Exp Ther Med. 10:1615–1623. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vallianou NG, Evangelopoulos A, Schizas N
and Kazazis C: Potential anticancer properties and mechanisms of
action of curcumin. Anticancer Res. 35:645–651. 2015.PubMed/NCBI
|
|
26
|
Salvioli S, Sikora E, Cooper EL and
Franceschi C: Curcumin in cell death processes: A challenge for CAM
of age-related pathologies. Evid Based Complement Alternat Med.
4:181–190. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Das T, Sa G, Saha B and Das K: Multifocal
signal modulation therapy of cancer: Ancient weapon, modern
targets. Mol Cell Biochem. 336:85–95. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hoarau-Véchot J, Rafii A, Touboul C and
Pasquier J: Halfway between 2D and animal models: Are 3D cultures
the ideal tool to study cancer-microenvironment interactions? Int J
Mol Sci. 19(181)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lv D, Hu Z, Lu L, Lu H and Xu X: Three
dimensional cell culture: A powerful tool in tumor research and
drug discovery. Oncol Lett. 14:6999–7010. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vinod BS, Antony J, Nair HH,
Puliyappadamba VT, Saikia M, Narayanan SS, Bevin A and Anto RJ:
Mechanistic evaluation of the signaling events regulating
curcumin-mediated chemosensitization of breast cancer cells to
5-fluorouracil. Cell Death Dis. 4(e505)2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Serasanambati M, Chilakapati SR, Manikonda
PK, Kanala JR and Chilakapati DR: Anticancer effects of brucine and
gemcitabine combination in MCF-7 human breast cancer cells. Nat
Prod Res. 29:484–490. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen S, Liang Q, Xie S, Liu E, Yu Z, Sun
L, Shin MC, Lee SJ, He H and Yang VC: Curcumin based combination
therapy for anti-breast cancer: From in vitro drug screening to in
vivo efficacy evaluation. Front Chem Sci Eng. 10:383–388. 2016.
|
|
33
|
Hehlgans S, Eke I, Storch K, Haase M,
Baretton GB and Cordes N: Caveolin-1 mediated radioresistance of 3D
grown pancreatic cancer cells. Radiother Oncol. 92:362–370.
2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Storch K, Eke I, Borgmann K, Krause M,
Richter C, Becker K, Schrock E and Cordes N: Three-dimensional cell
growth confers radioresistance by chromatin density modification.
Cancer Res. 70:3925–3934. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
El-Ashmawy M, Coquelin M, Luitel K, Batten
K and Shay JW: Organotypic culture in three dimensions prevents
radiation-induced transformation in human lung epithelial cells.
Sci Rep. 6(31669)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Girdhani S, Ahmed MM and Mishra KP:
Enhancement of gamma radiation-induced cytotoxicity of breast
cancer cells by curcumin. Mol Cell Pharmacol. 1:208–217. 2009.
|
|
37
|
Peddada KV, Peddada KV, Shukla SK, Mishra
A and Verma V: Role of curcumin in common musculoskeletal
disorders: A review of current laboratory, translational, and
clinical data. Orthop Surg. 7:222–231. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Qiao Q, Jiang Y and Li G: Curcumin
enhances the response of non-Hodgkin's lymphoma cells to ionizing
radiation through further induction of cell cycle arrest at the
G2/M phase and inhibition of mTOR phosphorylation. Oncol Rep.
29:380–386. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Qiao Q, Jiang Y and Li G: Inhibition of
the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced
apoptosis in human Burkitt's lymphoma. J Pharmacol Sci.
121:247–256. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lia G, Wanga Z, Chonga T, Yangb J, Lia H
and Chena H: Curcumin enhances the radiosensitivity of renal cancer
cells by suppressing NF-κB signaling pathway. Biomed Pharmacother.
94:974–981. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Koháryová M and Kollárová M: Thioredoxin
system-a novel therapeutic target. Gen Physiol Biophys. 34:221–233.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lu J and Holmgren A: The thioredoxin
antioxidant system. Free Radic Biol Med. 66:75–87. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Stafford WC, Peng X, Olofsson MH, Zhang X,
Luci DK, Lu L, Cheng Q, Trésaugues L, Dexheimer TS, Coussens NP, et
al: Irreversible inhibition of cytosolic thioredoxin reductase 1 as
a mechanistic basis for anticancer therapy. Sci Transl Med.
10(eaaf7444)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Daverey A and Agrawal SK: Curcumin
alleviates oxidative stress and mitochondrial dysfunction in
astrocytes. Neuroscience. 333:92–103. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lechner S, Müller-Ladner U, Neumann E,
Spöttl T, Schlottmann K, Rüschoff J, Schölmerich J and Kullmann F:
Thioredoxin reductase 1 expression in colon cancer: Discrepancy
between in vitro and in vivo findings. Lab Invest. 83:1321–1331.
2003.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Koedrith P and Seo YR: Induction of
doxorubicin-mediated apoptosis via thioredoxin reductase 1RNAi in
human colon cancer cells. Mol Cell Toxicol. 7:112–119. 2011.
|
|
47
|
Eriksson SE, Prast-Nielsen S, Flaberg E,
Szekely L and Arnér ES: High levels of thioredoxin reductase 1
modulate drug-specific cytotoxic efficacy. Free Radic Bio Med.
47:1661–1671. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Shakibaei M, Kraehe P, Popper B, Shayan P,
Goel A and Buhrmann C: Curcumin potentiates antitumor activity of
5-fluorouracil in a 3D alginate tumor microenvironment of
colorectal cancer. BMC Cancer. 15(205)2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Shao FY, Du ZY, Ma DL, Chen WB, Fu WY,
Ruan BB, Rui W, Zhang JX, Wang S, Wong NS, et al: B5, a thioredoxin
reductase inhibitor, induces apoptosis in human cervical cancer
cells by suppressing the thioredoxin system, disrupting
mitochondrion-dependent pathways and triggering autophagy.
Oncotarget. 6:30939–30956. 2015.PubMed/NCBI View Article : Google Scholar
|
